|
PRKAR1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.058800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.357220E-01 |
| Normal-vs-Stage2 |
3.676200E-01 |
| Normal-vs-Stage3 |
7.890800E-01 |
| Normal-vs-Stage4 |
6.921800E-01 |
| Stage1-vs-Stage2 |
9.727600E-01 |
| Stage1-vs-Stage3 |
4.965600E-02 |
| Stage1-vs-Stage4 |
1.372170E-01 |
| Stage2-vs-Stage3 |
2.593600E-01 |
| Stage2-vs-Stage4 |
2.511600E-01 |
| Stage3-vs-Stage4 |
8.684200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.897800E-01 |
| Normal-vs-AfricanAmerican |
6.931900E-02 |
| Normal-vs-Asian |
4.024000E-01 |
| Caucasian-vs-AfricanAmerican |
6.569800E-02 |
| Caucasian-vs-Asian |
6.417000E-01 |
| AfricanAmerican-vs-Asian |
2.407600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.819800E-01 |
| Normal-vs-Female |
1.141820E-01 |
| Male-vs-Female |
9.437200E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.203990E-01 |
| Normal-vs-Age(41-60Yrs) |
5.423600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.441800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.826600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.555200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.169980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.739800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.988600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.123400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.909400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.788500E-02 |
| Classical-VS-Follicular |
3.484600E-01 |
| Classical-VS-Other |
1.839780E-01 |
| Classical-VS-Normal |
9.415800E-02 |
| Tall-VS-Follicular |
3.309000E-01 |
| Tall-VS-Other |
5.176400E-01 |
| Tall-VS-Normal |
5.974400E-01 |
| Follicular-VS-Other |
3.615800E-01 |
| Follicular-VS-Normal |
5.973800E-01 |
| Other-VS-Normal |
3.289600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.056800E-01 |
| Normal-vs-N1 |
4.524800E-01 |
| N0-vs-N1 |
2.244600E-01 |
|
|
